WINNERS & LOSERS: Shield Therapeutics down on Medicaid concerns
1st May 2026 11:10
(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Friday. Read More
| Price | €3.88 on 13-05-2026 at 16:30:02 |
|---|---|
| Change | €0.00 0% |
| Buy | €4.00 |
| Sell | €3.76 |
| Last Trade: | Unknown 21,625.00 at €3.7916 |
| Day's Volume: | 74,609 |
| Last Close: | €3.88 |
| Open: | €3.88 |
| ISIN: | GG00BS874H38 |
| Day's Range | €3.88 - €3.95 |
| 52wk Range: | €0.418 - €3.95 |
| Market Capitalisation: | €150.06m |
| VWAP: | €3.8867 |
| Shares in Issue: | 38.68m |
Fair Oaks Inc (FAIR) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 21,625 | €3.7916 | Ordinary |
15:23:06 - 13-May-26 |
| Buy* | 2,000 | €3.95 | Ordinary |
11:05:19 - 13-May-26 |
| Buy* | 2,085 | €3.95 | Suspected BUY Trade |
11:00:14 - 13-May-26 |
| Unknown* | 2 | €3.796589 | Currency Conversion Negotiated Trade |
10:54:12 - 13-May-26 |
| Unknown* | 25,000 | €4.00 | Negotiated Trade |
09:35:34 - 13-May-26 |
| Unknown* | 3,553 | €3.795274 | Currency Conversion Negotiated Trade |
09:10:37 - 13-May-26 |
| Buy* | 371 | €3.95 | Suspected BUY Trade |
09:00:19 - 13-May-26 |
| Unknown* | 19,973 | €3.85 | Ordinary |
08:05:58 - 13-May-26 |
| Sell* | 3,600 | €3.80 | Ordinary |
16:36:39 - 12-May-26 |
| Buy* | 5,000 | €3.90 | Ordinary |
16:16:32 - 12-May-26 |
Fair Oaks Inc (FAIR) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 8th May 2026 7:00 am | RNS | Reinvestment of Management Fees |
| 1st May 2026 5:42 pm | RNS | Total Voting Rights |
| 1st May 2026 7:00 am | RNS | Transaction in Own Shares |
| 30th Apr 2026 2:30 pm | RNS | Result of EGM and Class Meeting |
| 30th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 28th Apr 2026 7:00 am | RNS | Replacement: Circular & Shareholder Meeting Notice |
| 28th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 23rd Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 22nd Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 21st Apr 2026 7:00 am | RNS | Annual Financial Report |